Annual CFI
-$12.00 K
+$431.20 K+97.29%
September 30, 2024
Summary
- As of February 26, 2025, SONN annual cash flow from investing activities is -$12.00 thousand, with the most recent change of +$431.20 thousand (+97.29%) on September 30, 2024.
- During the last 3 years, SONN annual CFI has fallen by -$8400.00 (-233.33%).
Performance
SONN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
N/A
December 31, 2024
Summary
- SONN quarterly cash flow from investing activities is not available.
Performance
SONN Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
N/A
December 31, 2024
Summary
- SONN TTM cash flow from investing activities is not available.
Performance
SONN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
SONN Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +97.3% | - | - |
| 3 y3 years | -233.3% | - | - |
| 5 y5 years | -100.0% | - | - |
SONN Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -233.3% | +98.5% | ||||
| 5 y | 5-year | <-9999.0% | +98.5% | ||||
| alltime | all time | <-9999.0% | +98.5% |
Sonnet BioTherapeutics Holdings Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$12.00 K(-97.3%) | $0.00(-100.0%) | -$12.00 K(-93.4%) |
| Jun 2024 | - | -$12.00 K(<-9900.0%) | -$182.00 K(0.0%) |
| Mar 2024 | - | $0.00(-100.0%) | -$182.00 K(-58.9%) |
| Sep 2023 | -$443.20 K(-45.3%) | -$170.00 K(+1316.7%) | -$443.20 K(+109.6%) |
| Jun 2023 | - | -$12.00 K(-95.4%) | -$211.50 K(-73.1%) |
| Mar 2023 | - | -$261.20 K(-523.3%) | -$785.80 K(-3.0%) |
| Sep 2022 | -$810.20 K | $61.70 K(-110.5%) | -$810.20 K(-7.5%) |
| Jun 2022 | - | -$586.30 K(+254.0%) | -$875.50 K(+202.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$165.60 K(+38.0%) | -$289.20 K(+134.0%) |
| Dec 2021 | - | -$120.00 K(+3233.3%) | -$123.60 K(+3333.3%) |
| Sep 2021 | -$3600.00(-95.3%) | -$3600.00(<-9900.0%) | -$3600.00(<-9900.0%) |
| Jun 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2021 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2020 | - | $0.00(-100.0%) | -$19.70 K(0.0%) |
| Sep 2020 | -$76.20 K(<-9900.0%) | - | - |
| Mar 2020 | - | -$19.70 K | -$19.70 K |
| Sep 2019 | $0.00 | - | - |
FAQ
- What is Sonnet BioTherapeutics Holdings annual cash flow from investing activities?
- What is the all time high annual CFI for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings annual CFI year-on-year change?
- What is the all time high quarterly CFI for Sonnet BioTherapeutics Holdings?
- What is the all time high TTM CFI for Sonnet BioTherapeutics Holdings?
What is Sonnet BioTherapeutics Holdings annual cash flow from investing activities?
The current annual CFI of SONN is -$12.00 K
What is the all time high annual CFI for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high annual cash flow from investing activities is $0.00
What is Sonnet BioTherapeutics Holdings annual CFI year-on-year change?
Over the past year, SONN annual cash flow from investing activities has changed by +$431.20 K (+97.29%)
What is the all time high quarterly CFI for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high quarterly cash flow from investing activities is $61.70 K
What is the all time high TTM CFI for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high TTM cash flow from investing activities is $0.00